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ABSTRACT
Background Small, wearable monitors are widely used to assess physical activity (PA) in obesity
treatment programs ranging from lifestyle interventions to post-bariatric surgical programs.
Although wearable monitors can overcome the recall biases often associated with self-reports,
the accuracy of these devices may be impacted by anthropometric measures, mode of PA, and
wear location. Thus, it is important to examine the accuracy of objective PA monitors during
commonly performed activities such as walking.
Methods Fifteen individuals with class III obesity completed a self-paced 6-minute walk while
wearing the StepWatch 3 (SW3), Omron, Digiwalker (DW), SenseWear Pro 2 Armband (SWA),
and Fitbit objective PA monitors. Simultaneously, energy expenditure (EE) was measured using
a portable indirect calorimeter. Height, weight, hip circumference, and waist circumference were
also measured. Monitor values for step counts and Calories were compared to hand tally counts
and indirect calorimetry (IC), respectively.
Results Step-counting percent errors (PE) were not significantly different among the SW3
(PE=0.56%), Omron (PE=5.53%), and Fitbit (PE=4.33%). The DW significantly undercounted
steps by 28% (p=0.037). The SWA overestimated EE by 71.6% (p=0.003), while the Fitbit’s 10%
overestimate did not differ significantly from IC (p=0.114).
Conclusion Objective monitors are useful for step counting and estimating energy expenditure,
but consideration should be given to device accuracy when selecting evaluative tools for the
bariatric population.
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CHAPTER 1
INTRODUCTION
Increasing rates of obesity are being reported globally, with the sharpest rises in
prevalence coming in the highest BMI categories [1]. These individuals, classified as having
class III obesity, are also afflicted by a long list of chronic diseases associated with excessive
adiposity [2-4]. Weight loss is capable of improving health [5], and bariatric surgery has
previously been described as the most effective option for long-term weight loss in individuals
with morbid obesity [6]. The outcomes of these surgical procedures are largely dependent on
patient behavioral modifications [7], with those combining physical activity with dietary
restrictions achieving the greatest weight loss [8]. Thus, participation in physical activity appears
to be a necessity in improving both weight status and health in this population.
Persons with class III obesity, including those awaiting bariatric surgery, prefer walking
over all other modes of physical activity [9, 10]. Objective monitors, such as pedometers and
accelerometers, record step counts during walking. These devices offer clinicians a tool for
assessing adherence to walking-based exercise prescriptions, while also allowing patients to selfmonitor their own daily activity. In addition to recording steps, some monitors are able to
estimate both daily and physical activity energy expenditure.
Pedometers and accelerometers are excellent tools for collecting data both in and out of
the clinical setting. However, their accuracy may be compromised when worn by persons with
class III obesity. Large waist circumference and slow walking speed negatively impact device
accuracy during step counting [11], while speed and body composition regulate the metabolic
cost of walking [12]. The ability to accurately relate step counts to walking energy expenditure
would certainly aid in the prescription and monitoring of physical activity components of weight
1

interventions. Therefore, determining the accuracy of step-counting devices in persons with class
III obesity would benefit healthcare providers and patients alike.
While a number of objective monitors are capable of recording steps, newer technologies
are being integrated into the assessment of PA. Spring-levered and piezo-electric pedometers
rely on vertical accelerations at the hip to record steps. Accuracy of these devices is affected by
physical characteristics of the wearer and walking speed [11, 13, 14]. In contrast, the ankle-worn
StepWatch 3 Activity Monitor measures both vertical and horizontal accelerations and can
record steps in a wide range of epochs. Due to its remarkable accuracy, it is considered the
criterion for estimating steps in the free-living environment [15]. The SenseWear Pro 2 armband
is worn on the right tricep and uses a dual-axis accelerometer and galvanic skin response, heat
flux, and ambient temperature sensors to quantify PA [16]. This device has been used in several
evaluative studies focusing on PA behaviors of bariatric patients [17-19]. The Fitbit is a
relatively new objective monitor that records activity using a three-dimensional motion sensor
similar to that of the Nintendo Wii. To our knowledge, no study has been published on the
accuracy of this device in the severely obese.
By validating different objective physical activity monitors in persons with class III
obesity, future researchers will be able to choose which device is best-suited for studies
involving this population. With walking being the most widely prescribed form of physical
activity in this population [20], accurate assessments of this activity are needed to determine the
dose-response relationship between walking and health outcomes. Converting these step counts
into estimates of energy expenditure would allow clinicians to quantify caloric expenditure
during walking-based interventions. Therefore, the purposes of this study are to: 1) determine the
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accuracy of step counting devices when worn by individuals with class III obesity and 2)
estimate the metabolic cost of persons with class III obesity while walking at self-selected speeds.
RESEARCH QUESTION: How accurate are the step counts and Calorie costs recorded by
objective physical activity monitors when worn by individuals with class III obesity?
RESEARCH HYPOTHESIS: Accuracy will be compromised by class III obesity in all waistmounted devices. Persons with class III obesity will walk at slower speeds than are commonly
reported for normal weight individuals, but the metabolic cost of walking will be increased due
to the extra body mass.
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CHAPTER 2
REVIEW OF THE LITERATURE
INTRODUCTION
The prevalence of class III obesity in U.S. adults has risen from 0.9% between 1960 and
1962 to 6.2% between 2005 and 2006 [21]. This has led to an exponential increase in bariatric
surgeries being performed [22]. Physical activity (PA) plays an important role in both
maximizing post-surgical weight loss [8], while pre-operational PA is related to increased
volume and intensity of post-surgical PA [23]. The American College of Sports Medicine
(ACSM) suggests walking is the most appropriate form of exercise for individuals with class III
obesity [20]. Consideration must be given when prescribing walking-based PA to this population,
as the metabolic cost of walking increases with increasing body fatness [24]. Therefore, there is a
specific need for accurate assessments of both the volume and metabolic cost of walking in
individuals with class III obesity.

CLASS III OBESITY
The World Health Organization (WHO) [25] and the National Heart Lung and Blood
Institute (NHLBI) [5] define obesity as having a body mass index (BMI) of at least 30 kg·m-2.
This condition is accompanied by severe health implications, evinced by the WHO’s recent
declaration of obesity being one of the top five risk conditions in developed nations [26].
Variations in health risks can be attributed to the extent of an individual’s obesity [27-29],
warranting further classification. The NHLBI and WHO established three classes of obesity
based on BMI ranges. Class I and II obesity are defined as a BMI range of 30-34.99 kg·m-2 and
35-39.99 kg·m-2, respectively. An individual suffering from Class III obesity, interchangeably
4

referred to as extreme [5], severe, and morbid obesity [30], is diagnosed as having a BMI of at
least 40 kg·m-2, or being 100 lbs. overweight for men or 80 lbs. overweight for women. Although
the NHLBI and WHO classification charts end with class III obesity, the surgical literature often
includes class IV and V obesity. Class IV, or super obesity, encompasses a BMI range of 50-59.9
kg·m-2. Individuals with a BMI of 60 kg·m-2 or greater are said to suffer from Class V, or supersuper obesity [31].
PREVALENCE
While the prevalence of the obesity epidemic continues to increase globally [1], the
steepest rises are reported in the highest BMI categories. Within the past twenty years, the
worldwide prevalence of class III obesity has doubled [32]. Between 2000 and 2005, the number
of persons in the US with a BMI ≥40 kg·m-2 increased by 52% [33]. Perhaps more alarmingly,
there was a 75% rise in reported BMI’s ≥50 kg·m-2 during this same time period. As the heaviest
individuals seem to only continue to gain weight, the 95th percentile of BMI’s has shifted to the
right by 3.2 kg·m-2 [34]. Over 5% of all Americans are now believed to suffer from class III
obesity [33]. This would suggest that of approximately 300 million Americans, nearly 15 million
are severely obese.
While, class III obesity appears to show no homogeneity in regards to age, race, or sex
[35], certain groups may be more susceptible than others. The number of severely obese females
doubles that of males [34], with the highest prevalence being reported for black women (15%)
[32]. In terms of age, young adults are most affected by the rising rates of class III obesity. From
age 18 to 35, the average weight gain is 30 pounds, and those who are already overweight
experience the largest gains [36]. While these statistics are certainly cause for concern, the fact
that they may fall short of actual values is most disturbing. Stommel and Schoenborn [37] found
5

that only 72% of individuals with class III obesity actually reported having a BMI ≥40 kg·m-2.
Measured BMI was, on average, 2.12 kg·m-2 higher when compared to self-reported values. If
this underreporting was applied to the population, an additional 1.9% of Americans might suffer
from class III obesity [37].
COMORBIDITIES
While extreme adiposity may be the visual marker of class III obesity, underlying health
conditions, or comorbidities, may have the greatest impact on healthcare. The McGraw-Hill
Concise Dictionary of Modern Medicine [38] defines comorbidity as “the simultaneous presence
of 2+ morbid conditions or diseases in the same patient, which may complicate a patient's
hospital stay”. The long list of comorbidities commonly associated with class III obesity includes:
hypertension (HTN), type 2 diabetes mellitus (DM2), gastroesophageal reflux, depression,
nonalcoholic fatty liver disease, obstructive sleep apnea (OSA), osteoarthritis, urinary stress
incontinence, and breast, ovarian, gallbladder, and prostate cancers [2-4]. The most commonly
reported comorbidity is HTN, with 52.3% of severely obese individuals having been diagnosed
[27]. Bonfa et al. [39] report over 30% of class III obese persons suffer from depression, having
a mental well-being comparable to cancer survivors and tetraplegics [40]. These high Beck
Depression Inventory scores also coincided with poor perceptions of health-related quality of life
but were unrelated to anthropometric measures, presence of diabetes, hypertension, osteoarthritis,
or socioeconomic status [4]. Compared to normal weight individuals, severely obese persons are
5.1 times more likely to develop DM2 and 2.2 times more likely to be diagnosed with
dyslipidemia [27]. Not surprisingly, 20.7% of all adults diagnosed with DM2 are also severely
obese [41]. Excessive adiposity results in high intra-abdominal pressure and causes chronic
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hypoventilation [42], which could explain the high occurrence of pulmonary insufficiency in the
severely obese [28].
In addition to these individual comorbidities, many severely obese individuals are also
plagued by the metabolic syndrome. While it should be noted various medical societies have
slightly different definitions , the American Heart Association (AHA) and NHLBI define the
metabolic syndrome as a disease state in which an individual has three or more of the following
risk factors for heart disease: waist circumference ≥ 40 inches for males or ≥ 35 inches for
females, blood pressure > 130/85 mmHg, fasting triglyceride (TG) level > 150 mg/dl, fasting
high-density lipoprotein (HDL) cholesterol level < 40 mg/dl for men or < 50 mg/dl for women,
and fasting blood sugar > 100 mg/dl [43]. With increasing BMI comes a greater risk of being
diagnosed with two or more of these comorbidities [29], supporting a prior report that up to 65.5%
of severely obese individuals live with the metabolic syndrome [44]. In addition to the individual
complications resulting from each risk factor, the condition as a whole is also associated with
compromised health. For instance, presence of the metabolic syndrome is associated with a
three-fold risk of cardiovascular morbidity [2].
HEALTHCARE COSTS
With this long list of associated diseases, it should be no surprise that severely obese
individuals face a substantial financial burden. In 2002, normal weight individuals spent an
average of $4,000 per annum on health care; severely obese individuals spent double this amount
[45]. It is worthy to mention the vast majority of these costs are due to underlying diseases
associated with obesity. Of the total health care costs related to obesity, 85% can be attributed to
HTN, dyslipidemia, coronary heart disease, DM2, and stroke [46]. The gaps in healthcare
expenditures are also noticeable between obesity classes. There was a $2,717 spending
7

difference between women with class II and class III obesity, while the largest rise in costs for
men was between classes I and II [45]. Rising healthcare spending is also associated with higher
BMI in European countries. In the United Kingdom, there were significant differences between
medication expenditures associated with class III obesity in comparison to both classes I and II
[47]. To put these numbers into perspective, obese individuals (classes I,II, and III) spend 77%
more on medications than persons of normal weight; there is only a 28% difference in
medication costs between smokers and nonsmokers [48]. In addition to the exponentially higher
costs of health care, productivity as an employee may also be affected by weight status.
Individuals with class III obesity use twice as many sick days as the general population, while
also drawing twice as frequent disability pension [49]. These statistics divulge the economic
impact of class III obesity.

WEIGHT LOSS
The increasing prevalence of class III obesity cannot be blamed solely on a lack of desire
to lose weight or prevent weight gain. In fact, the exact opposite may be true. A previous study
reported up to 40% of women and 24% of men may be attempting to lose weight at any given
time [50]. While the health benefits of weight loss are clear [46, 49, 51-53], often times weight
loss efforts are ineffective in producing the necessary negative caloric balance. The reasons
behind failed weight loss attempts are numerous. As health is only one determining factor in
behavioral decision-making, this long-term outcome may be suppressed by more immediate
factors. For instance, the cost of a healthy diet may exceed that of one comprised of energydense, processed foods. With an abundance of unhealthy and readily available fast food options
and sedentary forms of electronic entertainment, today’s environment has become increasingly
obesogenic. With the addition of time constraints due to demanding schedules, these
8

environmental influences become even more exaggerated. Constant interaction with these
negative stimuli mandates successful weight loss programs address both dietary and PA
components [51].
RECOMMENDATIONS
According to the NHLBI [5], weight loss is indicated in all adults with a BMI ≥25 kg·m-2,
males with a waist circumference (WC) ≥ 102 cm, and females with a WC ≥ 88 cm. This same
report suggests reducing energy intake by 500-1,000 kcal·d-1, eliciting a minimum weight loss of
1 to 2 pounds per week. The American College of Sports Medicine (ACSM) advises striving for
a 5% to 10% reduction in body weight over 3 to 6 months, while reducing dietary fat to <30% of
total energy intake [20]. A more radical approach is through a very low calorie diet (VLCD),
where daily energy intake is reduced to 800 kcal. Supplementing existing information on dietary
modifications, the US Department of Health and Human Services (USDHHS) issued the 2008
Physical Activity Guidelines for Americans, where individuals seeking weight loss are
encouraged to engage in 300 minutes of moderate-to-vigorous physical activity (MVPA) weekly
[54]. The ACSM proposed similar guidelines, recommending 60 to 90 minutes of MVPA daily
for weight loss and/or maintenance [20]. The USDHHS’s Dietary Guidelines for Americans,
2010 reiterates the importance of PA participation in achieving caloric balance and maintaining
weight [55].
CURRENT DIET
When considering the elevated energy intake of class III obese persons, reductions in
caloric intake must be a primary focus in producing a negative energy balance. In a study of 34
severely obese individuals, average reported caloric intake totaled 3,442 ± 814 kcal·d-1; the
average recommended caloric intake for their body size was 2,357 ± 511 kcal·d-1 [56]. This
9

difference results in a positive energy balance of over 1,000 kilocalories each day. These figures
become even more alarming when considering bariatric patients are likely to underreport energy
intake [57]. A similar study reported that class III obesity was associated with consuming 464
kcal·d-1 than normal weight individuals [58]. This difference approximates the 500 kcal·d-1
reduction recommended for weight loss.

WEIGHT LOSS MAINTENANCE
Obesity is now considered a chronic disease that requires long-term support for proper
management [59]. While previous studies have shown diet and exercise to produce modest
weight loss initially [60-62], long-term maintenance of this weight loss appears to present the
biggest challenge. Wing and Hill [63] defined successful weight loss maintenance as
“intentionally losing at least 10% of initial body weight and keeping it off for at least 1 year.”
This 10% criterion is derived from numerous prior reports clearly documenting health benefits as
a direct result of this percentage of weight loss [5]. Although this 10% reduction in body weight
is unlikely to return an obese person to normal weight, it may still provide significant
improvements in health. The famed Diabetes Prevention Program [64] proved even a 7%
reduction in initial body weight through lifestyle changes can produce significantly greater
reductions in risk of developing DM2 than pharmaceutical treatment. A similar study on Finnish
subjects achieving an average 2-year weight loss of 3.5 kg reduced subjects’ risk of developing
DM2 by 58% [53]. Oster et al. [46] report a 10% reduction in body weight may avert three years
of HTN and approximately two years of DM2. This same 10% reduction in body weight was
also predicted to decrease medical care costs by over $5,000. Urinary incontinence in women
may also improve with modest 5-10% reductions in body weight [36]. At ten years of follow-up,
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this weight loss corresponds to significant improvements in health-related quality of life (HRQL)
scores in the severely obese [65].
REASONS FOR WEIGHT REGAIN
Maintenance of this weight loss appears to pose the greatest challenge. Most individuals
will regain 1/3 to 2/3 of the weight lost within the first year of starting a program [50]. Maclean
et al. [66] report those unable to maintain weight loss had returned to their initial body weight by
five years follow-up. Furthermore, these investigators found the rate of weight regain appeared
to be at its highest immediately after cessation of the weight loss program [66]. One proposed
explanation for this increase in body weight following weight reduction is a metabolic drive for
excessive energy intake [66, 67]. In the weight-reduced state, carbohydrates (CHO) become the
primary fuel, and fat oxidation appears to be suppressed [67]. This not only allows for greater
deposition of fat into adipose tissue but may also trigger hunger signaling with depletion of CHO
stores. Recommendations suggest keeping dietary fat below 30% of total caloric intake [20],
potentially discouraging accumulation of adipose stores. It appears the best prevention of weight
regain is life-long dedication to sustaining both reductions in caloric intake and improvements in
PA participation.
EFFECTIVE STRATEGIES
Determining which approaches are most effective for continued weight control is of
utmost importance in combatting weight regain. Established in 1994, the National Weight
Control Registry (NWCR) is a database of individuals who have successfully preserved an
average weight loss of 33 kg (72.6 lbs) for 5.7 years [68]. These individuals report utilizing a
variety of strategies to fend off weight regain. The most commonly reported of these strategies
are consumption of a low-calorie, low-fat diet, physical activity, and frequent self-weighing [69].
11

These individuals report a caloric intake just over 1,300 kcal/day and exercise energy
expenditures sometimes exceeding 3,200 kcal/day [68].
Behavioral modifications have been shown to also produce encouraging results in
persons with class III obesity. Unick et al. [52] report severely obese individuals in the Look
AHEAD trial lost a greater percent of initial body weight than did overweight, class I, and class
II obese individuals. Similarly, a 12-week intervention focusing on behavioral modifications
produced an average 25% reduction in initial body weight in 1,100 severely obese patients [70].
Furthermore, these patients upheld 59% of this weight loss at the 72-week follow-up. Those who
effectively maintain weight loss for two years reduce their odds of weight regain by nearly 50%
[69]. However, meta-analysis of 29 behavioral interventions revealed just over a 3% reduction of
initial body weight for all participants at 5-year follow-up [71].
To curb potential relapses, long-term contact with patients may be crucial in successful
maintenance of weight loss. Perri et al. [72] found that patients who remained in contact with
clinicians maintained significantly greater weight loss. Sustained contact may not be as
challenging as it would seem, so long as continued clinical supervision is offered. When given
the option, 87% of severely obese patients who had lost ≥ 100 lbs. during a weight loss
intervention subsequently enrolled in an optional maintenance program [70]. This additional
support after cessation of the structured program may be essential for long-term weight
maintenance.

BARIATRIC SURGERY
OVERVIEW
Whereas behavioral modifications often elicit meager long-term weight loss outcomes,
bariatric surgery has grown in popularity and is now considered the most effective long-term
12

weight loss treatment [6]. Bariatric surgery entails a procedure or procedures that induce weight
loss through limiting energy intake (restriction), reducing energy absorption (malabsorption), or
both. In 1991, the National Institutes of Health (NIH) established the first guidelines for bariatric
surgery, reserving its use for patients with a BMI ≥ 40 kg·m-2 or ≥35 kg·m-2 with high-risk
comorbid conditions [73]. At the time these guidelines were published, less than 5,000 bariatric
surgeries were performed annually; by 2009, this number increased to 220,000 [22]. The most
commonly performed procedure is Roux-en-Y gastric bypass (RYGB) [2, 74]. RYGB combines
restriction and malabsorption, reducing the stomach pouch to approximately 20 ml and
bypassing the duodenum and a variable portion of the proximal jejunum [2]. Other common
procedures include laparoscopic adjustable gastric banding (LAGB) and laproscopic sleeve
gastrectomy (LSG). The latter is typically reserved for patients presenting with a BMI ≥ 60
kg·m-2 or at a high risk for peri-operative morbidity and mortality [75]. The costs of these
procedures and related medical care ranges from $20,000 to $50,000 [76]. In 2002, $948 million
in healthcare spending was attributable to bariatric surgery [77].
PATIENT CHARACTERISTICS
Patient populations in studies involving bariatric surgery are characteristically similar to
one another. Between 70% and 90% of persons presenting for weight loss surgery are women [7,
17, 78-81], and only about 10% of patients are nonwhite [7, 82, 83]. The onset of obesity
normally occurs during early childhood [7], indicating the majority of these patients live with
obesity for much of their lives. In addition, Bonfa et al. [39] report 27% of patients considering
weight loss surgery had a family history of obesity. Over half of patients awaiting bariatric
surgery suffer from two comorbidities, while 25% have been diagnosed with 3 or more [82]. The
most commonly reported comorbidities are HTN (55.1%), OSA (48.9%), osteoarthritis (44.7%),
13

and DM (33.2%) [7, 17]. These individuals suffer not only from physical and metabolic
conditions, but also psychological disorders. Binge eating disorder [84] and depression [7] are
two of the most prevalent psychological disorders clinicians must address during patient
evaluations.
OUTCOMES
Although bariatric surgery produces significantly better long-term outcomes than
conventional strategies [49, 85, 86], wide inter-individual and inter-procedural variation has been
reported. In an effort to adjust for inter-individual differences in absolute body weight, weight
loss outcomes are typically reported as the percentage of excess body weight lost (%EWL).
Previous studies report greater weight loss outcomes from RYGB than LAGB [74, 79, 86-88].
These studies show RYGB results in ≥60% EWL, compared to <50% for LAGB. However,
the %EWL 2- to 3-years post-operation has been shown to range from 24.9% to 92.1% [17].
Longer follow-up periods have exposed that even surgery cannot fully prevent weight regain.
Between 3- and 5-years post-operation, approximately 20% of RYGB patients did not achieve 50%
EWL [89]. Karlsson et al. [65] report patients who had undergone bariatric surgery had regained
1/3 of their initial weight loss by 6-year follow-up. In a study comparing the outcomes of shortand long-limb gastric bypass procedures, significant weight gain occurred in both surgical
groups between 5- and 10-years follow-up [90]. In contrast, other studies have reported the
ability of patients to sustain >50% EWL for over 15 years after the procedure [79, 88]. It is also
worth mentioning that, out of 300 consecutive RYGB procedures, no patient gained weight
postoperatively [7].
What factors affect post-surgical weight loss outcomes? Both pre- and post-operative
patient characteristics and behaviors certainly play a crucial role. Most insurance companies
14

require enrollment in a 6- to 12-month clinically supervised weight loss program prior to
operation. This stipulation is to gauge patient adherence to medical staff instruction; pre-surgical
weight loss is generally not mandatory [22]. Therefore, these programs may fail to evaluate the
individual’s motivation to attempt pre-operational weight loss through prescribed lifestyle
modifications. Higher initial BMI has been associated with a slower rate of weight loss and
poorer %EWL. Individuals presenting with BMI’s ≥ 50 achieved a significantly lesser % EWL
than those with BMI’s between 40 and 50 kg·m-2 and regained 9% more of their pre-operative
body weight at 6-year follow-up [91]. Approximately 70% of patients with a BMI >50 failed to
achieve a BMI <35 at least 10 years after having undergone biliopancreatic diversion [92].
Despite these findings on the detrimental effect of a high pre-operational BMI on weight loss
outcomes, the American Society for Metabolic and Bariatric Surgery (ASMBS) has recently
published a position statement claiming a lack of evidence supporting the need for pre-surgical
weight loss programs [93]. In a study determining predictors of post-surgical outcomes, initial
BMI, level of education, presence of DM, PA participation, and post-operative appointment
attendance explained 41% of the variability in weight loss following RYGB [7]. In this same
study, patients with limited participation in PA achieved 17.2% less EWL than more active peers,
whereas presence of DM2 hindered EWL by 6.2%. Following the post-surgical plateau in weight
loss, Silver et al [94] identified current age, weight at age 21, initial BMI, and level of
participation in PA as significant predictors of current BMI. In addition to patient behaviors and
descriptors, surgeon experience has also been linked to post-operative weight loss outcomes [95].
While many factors appear to influence degree of weight loss achieved, the favorable effect of
PA is evident.
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PHYSICAL ACTIVITY
PA has been implicated as a vital component for successful weight loss and weight loss
maintenance. It is also the only component of total energy expenditure that is modifiable from
day to day [96]. The average caloric intake for 90% of 20- to 40-year-olds results in a positive
energy balance of no more than 50 kcals·d-1, but this small imbalance leads to an average weight
gain of 1.8 to 2.0 lbs per year [97]. Minimal increases in daily PA could easily curb this trend
toward weight gain. Participation in PA reduces the extent of dietary restrictions necessary to
achieve a negative energy balance.
RECOMMENDATIONS
The USDHHS issued PA recommendations in the 2008 Physical Activity Guidelines for
Americans [54]. The recommendations state that all should adults engage in 150 minutes of
moderate-to-vigorous physical activity (MVPA) or 75 minutes of vigorous physical activity
(VPA) each week, accumulated in bouts of at least 10 minutes. MVPA and VPA are expressed as
multiples of resting energy expenditure (REE), or 1 metabolic equivalent (MET). MVPA is
defined as any activity of 3.0-5.9 METs, and VPA entails all activities ≥ 6 METs. In other words,
a 3.0-MET activity corresponds to a 3-fold increase in REE. At least 300 minutes of MVPA (150
min VPA) each week are recommended to induce weight loss [54]. In addition to this aerobic
activity, resistance training at least twice each week is also recommended. A recent report has
shown up to 50% of Americans fail to meet the recommendations for aerobic activity, and only
18.2% engage in the recommended volumes of both aerobic and resistance exercise [98].
COMPLIANCE
While a large percentage of the general population meets the national PA guidelines,
severely obese individuals are much less active. Only 4.3% of class III obese adults reported
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engaging in moderate PA, compared to 18.1% and 35.5% of class I obese and normal weight
individuals, respectively [27]. Using a multisensory armband to assess PA, Vanhecke et al. [99]
showed severely obese persons spent 23 hours and 51.6 minutes per day in activities of <3 METs.
The remaining 8.4 minutes were spent in moderate activity, with no individual spending any
amount of time in VPA. The highest amount of activity recorded for any individual was 28
minutes per day, still falling short of the established recommendations.
Rates of physical inactivity appear to elevate in the highest BMI categories. Persons with
a BMI ≥50 spend nearly an extra hour each day in sedentary behaviors than those with BMI’s
ranging from 35 to 49.9 [19]. Both leisure-time and occupational levels of PA are significantly
lower in women with class III obesity than normal weight women, while daily television
viewing is significantly higher [42]. Only 4.5% of patients awaiting bariatric surgery meet the
150 min·wk-1 of MVPA recommendation, while over 68% engage in no bouts of at least 10
minutes [80]. Additionally, only 14% of patients presenting for surgery have been in a PA
program for at least 6 months [100]. This statistic alone conveys the lack of importance placed
on PA in the required pre-operational weight loss programs. These percentages do appear to
improve following surgery. Evans et al. [8] found 57.4% of patients self-reported engaging in
≥150 min·wk-1 of MVPA one year after gastric bypass. However, after adjusting for the 10minute bout criterion patients’ post-operative time in MVPA fell from an average of 212.8
min·wk-1 to 49.3 min·wk-1 [17]. While PA does appear to increase following surgery, postoperative noncompliance rates are higher for PA than all other prescribed behavioral changes
[101]. Clearly, low rates of participation in PA are a concern in this rapidly growing population.
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MET CONTROVERSY
Before blaming the rising rates of class III obesity on failure to meet existing PA
guidelines, special consideration must first be given to how intensity of exercise is determined.
As previously mentioned, the 2008 Physical Activity Guidelines for Americans [54] classify
intensity of exercise using multiples of 1 MET, or an oxygen consumption of 3.5 ml·kg-1·min-1.
This value was derived from a 70 kg, 40-year-old man [102], and the general population may
have values significantly lower than the referent [103]. Use of this 1-MET value to quantify
intensity of PA leads to misclassification of many activities, and the rate of misclassification may
be highest in sedentary, obese individuals [104].
Adipose tissue is only about 25% as active as fat free mass [105], so excessive adiposity
in the severely obese reduces resting metabolic rate (RMR) [106, 107]. The effect of adiposity on
RMR can be partly attributable to a lower proportion of slow-twitch muscle fibers [108]. This
smaller portion of oxidative muscle fibers helps explain the 45% lower mitochondrial respiratory
capacity and decreased mitochondrial uncoupling in severely obese compared to normal weight
individuals [109]. Where normal weight individuals release energy as heat, the impaired
mitochondrial uncoupling accompanying class III obesity results in greater energy storage. Each
of these factors contributes to the lower RMR associated with class III obesity.
As the level of obesity increases, the 1-MET value assigned to RMR becomes less
applicable. Sleeping has previously been assigned a value of 0.9 METs [110]; the RMR of
severely obese individuals may be lower than this [103]. A 3.0-MET activity (10.5 ml·kg-1·min-1)
would, in turn, be more intense for a severely obese person with a low RMR than by a lean
individual with a higher RMR.
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PA & WEIGHT LOSS
Of persons seeking to lose weight or working to maintain weight loss, those utilizing both
diet and exercise are most successful [111]. Following a VLCD, obese persons engaging in high
levels of PA reduced weight by 17.5 kg, whereas the moderate exercisers lost 9.3 kg at 2- to 3year follow-up [61]. Exercise has been proposed to enhance adherence to dietary restrictions
[112], in turn, resulting in greater weight loss. The hypothalamic response to caloric restriction
may be blunted through habitual PA, attenuating the desire to overfeed [66, 113]. Another study
corroborates this theory by noting that no compensatory increase in caloric intake occurred
following exercise [114]. Weight loss through caloric restriction alone may be detrimental to fat
oxidation, as it has been found to decrease mitochondrial size [115]. PA was capable of
increasing oxidative enzyme activity and mitochondrial volume, potentially overriding this
disadvantageous effect of diet.
Fat-free mass (FFM) is the central determinant in RMR [116] and explains 69% of the
variance in RMR of formerly obese individuals following weight loss [117]. Individuals
engaging in PA following weight loss surgery gained 8% more FFM than did non-exercising
peers [118]. The ability of PA to attenuate loss of FFM clearly demonstrates its impact on total
energy expenditure.
In comparison to dietary therapy alone, the addition of PA increases weight loss
outcomes through greater caloric expenditure. Severely obese adults who participated in a 12month diet and exercise weight loss intervention lost significantly more weight than those
following the same program but beginning PA at 6 months [119]. Exercise prescriptions of
varying intensity and duration (vigorous intensity/high duration, moderate intensity/high duration,
moderate intensity/moderate duration, and vigorous intensity/moderate duration) leading to
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weekly energy expenditures of 1,000 kcal and 2,000 kcal, combined with caloric restriction,
produced no significant differences in weight loss between groups of obese, formerly sedentary
women [120]. These results suggest the role of caloric expenditure resulting from PA, in terms of
weight loss, supersedes that of intensity and duration. Persons with class III obesity may have
difficulties engaging in high-intensity PA, so these results are particularly important for this
population.
PA plays an important role in the maintenance of weight loss as well. Nearly 90% of
NWCR participants reported combining diet and PA, while only 10% used diet alone [68]. In
comparison to those who regained weight, successful maintainers expended approximately 2,000
kcal·wk-1 more in PA [121]. Subsequent weight regain also varies when comparing diet and PA.
Unlike weight regain following dietary-induced weight loss, weight regain after PA-induced
weight loss is independent of the preceding weight reduction [122]. PA plays a critical role in
both maximizing initial weight loss and maintaining that weight loss over time.
PA & BARIATRIC SURGERY
PA has also been shown to enhance the effects of weight loss surgery [7, 8, 17, 74, 123],
while physical inactivity has been described as one of the two most detrimental factors to postsurgical weight loss outcomes [124]. Participation in pre-operational PA may also correlate with
post-surgical weight loss. Those patients incapable of walking two city blocks lost 17.2% less
excess body weight at 1-year follow-up [7]. In addition, becoming physically active before
surgery may increase post-operational levels of PA and the intensity of this activity [23].
Following gastric bypass, patients who engaged in 150 min·wk-1 of MVPA experienced
significantly greater weight loss, reductions in BMI, %EWL, and total percentage of weight lost
than those failing to meet PA recommendations [8]. As much as 35% of weight lost at 1-year
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post-operation is FFM, and this loss of FFM is directly correlated to the decrease in absolute
RMR [125]. Individuals who reported engaging in post-operative PA significantly increased both
FFM and percentage of fat mass lost in comparison to non-exercisers [118]. In a similar study,
PA actually increased muscular strength following gastric bypass [126]. Non-exercising controls
lost significant amounts of strength in their quadriceps (-16%), biceps (-36%), and triceps (-39%).
Therefore, it appears PA increases surgically-induced weight loss through both increasing energy
expenditure and retaining or increasing FFM. Though PA improves weight loss outcomes, there
are currently no available guidelines on exercise following bariatric surgery.
BENEFITS BEYOND WEIGHT LOSS
Participation in PA has implications outside of increasing weight loss outcomes.
Physically active obese individuals have lower risks of mortality and morbidity than physically
inactive lean individuals, and physical inactivity is as strong a predictor of mortality as is obesity
[127]. Obese adults who engaged in at least 2 hours of weekly PA reduced their risk of
developing the metabolic syndrome by 19% [44], while accumulating 150 minutes of MVPA per
week reduced the risk of developing glucose intolerance, dyslipidemia, and hypertension by 86%
[128]. Meeting the 2008 PA guidelines is also associated with a reduced prevalence of the
metabolic syndrome [129]. Aerobic capacity is linked to cardiovascular disease [130] and is
improved with PA participation [131, 132]. This is particularly important in the severely obese,
as their fitness levels are not significantly different than those of individuals diagnosed with heart
failure [133]. After adjusting for cardiorespiratory fitness, neither obesity nor presence of
metabolic syndrome are significantly related to risk of all-cause mortality [134]. A 1-MET
increase in aerobic capacity has been associated with up to a 35% reduction in all-cause
mortality [135] and a 5.4% reduction in healthcare costs [130]. Cardiorespiratory fitness is also
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inversely associated with surgical complications following gastric bypass [130]. Following
bariatric surgery, cardiorespiratory fitness may decrease as a result of decreased FFM [125, 136]
and reduced cardiovascular strain from the drastic weight reduction [137]. An exercise program
would be necessary in both maintaining lean tissue and heart function, and has been shown to
increase post-operative aerobic capacity by as much as 50% [138]. Bariatric surgery is probably
incapable of improving cardiovascular function without accompanying exercise participation. In
the absence of post-operative PA, weight loss surgery had no significant effect on resting heart
rate (HR) or blood pressure [138]. Bariatric surgery does not typically impact high-density
lipoprotein (HDL) cholesterol levels [79], but PA has been shown to improve HDL in obese
individuals [139]. In comparison to non-exercisers, individuals participating in post-surgical PA
improve health outcomes beyond weight loss alone.

WALKING FOR PHYSICAL ACTIVITY
The benefits of incorporating PA into any weight loss program are clear; the difficulty
lies in developing approaches capable of arousing weight loss seekers to begin an exercise
regimen. One of the most effective methods may be to encourage walking, particularly in
persons with class III obesity [20]. The health benefits of walking are well documented [140142], and most individuals walk to perform common tasks each day. Walking does not require an
often expensive health club membership, carries a low risk for injury, and can be performed
alone or with a group [132], making it one of the most convenient modes of PA. In addition to
walking, the ACSM lists cycle ergometry as an appropriate form of exercise in the severely
obese population [20]. However, the heart rate response relative to the oxygen requirement of
cycling far exceeds that of walking [106]. In practical terms, an individual with class III obesity
would be forced to cycle for a longer duration at a higher heart rate to attain an equal caloric
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expenditure to that of walking. Additionally, walking may alleviate some of the perceived
barriers to PA reported by persons with class III obesity. While severely obese patients seeking
weight loss treatment show a desire to become physically active [78, 138], concerns about
wearing tight-fitting sports clothing and a lack of accommodating exercise equipment were
common obstacles [143]. Walking appears to be a viable solution to alleviating these hindrances.
PREVALENCE OF WALKING
Walking seems to be the most appealing type of LTPA across BMI categories. A higher
percentage of obese men (33.9%) walk for LTPA than overweight (30.0%) and normal weight
(28.0%) peers, while the percentage of obese women (45.6%) reporting walking is comparable to
those of overweight (49.1%) and normal weight (47.5%) groups [9]. Walking is also the most
common type of PA reported by individuals seeking or maintaining weight loss. Of adults trying
to lose weight, 37.7% of men and 52.5% of women incorporated walking into their weight loss
strategies [144]. In a study evaluating exercise in patients awaiting bariatric surgery, 44% of
reported PA came from walking [10]. Also an effective tool in maintaining weight loss, 76% of
individuals enrolled in the NWCR reported walking for PA [68]. These data suggest walking
may be the mode of exercise most prone to impact PA levels of the severely obese while also
playing a critical role in weight loss maintenance.
RECOMMENDATIONS
Walking is believed to be the most successful tool for increasing PA, from a public health
perspective [145]. This has led to an interest in establishing guidelines specific to walking. The
10,000 steps-per-day goal is perhaps the most recognizable guideline in place today and has been
employed in numerous walking-based PA interventions [140, 146, 147]. Tudor-Locke and
Bassett [148] proposed indices based on daily step counts for classifying PA levels. Individuals
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accumulating at least 10,000 steps each day were classified as active. This cut-off seems
appropriate, as 73% of individuals meeting the 30 min·d-1 guidelines also walked 10,000
steps·d-1 [149]. In turn, sedentarism was defined as taking fewer than 5,000 daily steps.
Speed must also be considered when establishing walking recommendations. The 2008
Physical Activity Guidelines for Americans [54] suggest walking at least 3 mph for MVPA,
while Ainsworth et al. [110] define “walking for exercise” as a speed of 5.6 km·h-1 (3.48 mph).
Stepping rate has also been used to quantify the intensity of walking. Taking 3,000 steps in thirty
minutes has previously been proposed as a cut-point for MVPA [148, 150]. However, the current
standardized intensities for walking do not consider individual differences in body size and may
not be appropriate for use in exercise prescriptions across differing populations [110]. The
applicability of these step goals to the severely obese population has yet to be determined.
CONSIDERATIONS FOR CLASS III OBESITY
Although walking is the most commonly reported form of PA in the severely obese, these
individuals fall far short of reaching current recommendations. Using the cut-points proposed by
Tudor-Locke and Bassett [148], 20% of patients awaiting bariatric surgery were sedentary, and
81% failed to accumulate 10,000 steps per day [10]. In this same study, BMI was inversely
related to both daily steps and steps per minute during the most active 30 minutes of the day.
Vanhecke et al. [99] found severely obese subjects took an average of only 3,763 steps each day.
Several factors explain the negative impact of class III obesity on daily step counts. A 10
kg·m-2 increase in BMI was shown to coincide with over a 300% decrease in the likelihood of
completing a 400 m walk [151]. Percent body fat is positively correlated with the amount of
steps required to walk a given distance [149]. From this, those subjects with the highest levels of
adiposity are not only taking an insufficient amount of steps each day but are also covering a
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shorter distance. Low daily step counts may be largely attributable to physical limitations
associated with class III obesity. Walking one city block or up one flight of stairs may often
induce dyspnea in this population [28]. Skin friction, foot, knee, and low back pain, and hip
arthritis were all reported significantly more often by severely obese women after walking than
by normal weight peers [42]. In a study of 2,458 patients awaiting bariatric surgery, 16% used an
assistive device for walking and 64% experienced difficulties walking several blocks [151].
Interestingly, 41% of those reporting these difficulties did not have an objectively measured
mobility deficit. This may suggest physical discomfort is viewed as a barrier to walking, even
without a physician’s diagnosis. Whether the limitations to walking are real or perceived, class
III obesity is clearly associated with a decrease in daily steps.
WALKING SPEED
Speed is a determinant of walking intensity, and self-selected walking speed significantly
decreases as BMI and body weight increase [152]. Walking is believed to be most efficient in
terms of energy expenditure at speeds around 3 mph [153], and, in a study of adults aged 20-79,
only women over age 60 and men over age 70 were found to select comfortable walking speeds
below this standard [154]. This is a considerably faster pace than is commonly observed for
those with class III obesity. When asked to walk at a comfortable speed, severely obese women
awaiting weight loss surgery were found to walk at 1.7 mph [155]. The slowest comfortable
speed reported was a mere 0.81 mph, approximately ¼ the value corresponding to moderateintensity PA [155].
Walking speed is also used in the clinical assessment of both functionality and fitness,
commonly through use of the 6-minute walk test (6MWT). Previous studies have used the
6MWT to assess functional capacity in patients awaiting bariatric surgery [42, 156, 157].
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Average pre-operative walking speeds ranged from 1.6 to 2.96 mph, with larger standard
deviations as body weight increased [42]. The corresponding distances of these tests equals, on
average, only 55% of the values attained by normal healthy adults [158]. A similar study by King
et al. [151] found the average pre-operational walking speed to be 2.4 mph, but 24% of patients
walked at speeds slower than 2.13 mph. Additionally, each 10 kg·m-2 increase in BMI increased
time taken to walk 400 m by 10% [151]. Furthermore, patients with an average BMI of 69
kg·m-2 were previously found to be incapable of completing a 6-minute treadmill walk at 2 mph
without developing metabolic acidosis or exceeding a respiratory exchange ratio (RER) of 1.0
[159]. Also worthy of mention considering its high prevalence in class III obesity, the preferred
walking speed of 40- to 70-year-olds of varying weight statuses diagnosed with DM2 averaged
only 2.05 mph [160].
ADDITIONAL CONSIDERATIONS
Class III obesity places considerably greater stress on the cardiovascular system. For
instance, walking speeds between 2.8 to 3.3 mph require oxygen consumptions corresponding to
as much as 75% of this population’s maximal aerobic capacity [106]. While this may limit the
exercise capacity of severely obese individuals, walking at slow speeds may still provide
significant health benefits. When “walking for pleasure,” obese individuals reached 70% of agepredicted maximal HR, as opposed to 59% in the normal weight group [161]. Similarly,
Mattsson et al. [162] found walking at a self-selected, comfortable speed corresponded to 56%
and 36% of peak aerobic capacity in obese and lean women, respectively. The clinical
implication of these findings is emphasized when considering the obese groups attained these
higher values while walking at significantly slower speeds. This suggests that walking speed may
not be indicative of the relative effort of the activity, particularly when performed by severely
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obese individuals. Furthermore, even those individuals who walk at speeds below 2 mph have a
44% lower risk of developing heart disease than non-walkers [141]. Gallagher et al. [133]
proposed that walking speeds as slow as 1 mph may be enough to improve cardiorespiratory
fitness in severely obese persons. It can be gathered that this population is sure to benefit from
walking, regardless of whether or not the recognized standards for speed are being met.
METABOLIC COST OF WALKING
The metabolic cost of walking is dependent upon several factors and can differ greatly
between lean and obese individuals. Level of fitness, biomechanical efficiency, body
composition, walking speed, and environment are all determinants of the energy expenditure (EE)
during walking [12]. Body fatness is negatively correlated to walking efficiency [24]; the more
body fat an individual carries, the greater the energy requirement of walking. For example, a
100-kg obese individual burns approximately twice as many calories as a normal weight person
weighing 50-kg during a 1-mile walk [163]. Body weight has previously been shown to explain
up to 92% of the variance in the metabolic cost of walking at a given speed [106], while
Browning et al. [12] showed that body fat percentage accounts for 45% of these differences.
The interpretation of these and other studies is clear; adiposity has a considerable effect
on walking EE. Faster walking speeds may have a greater effect on those with a high degree of
body fat as a result of increased inertia, decreasing efficiency and, in turn, increasing EE [107,
164]. In a study comparing mass-specific gross EE during walking in lean and obese individuals
[106], no significant differences were found at 2.2 mph. At 2.9 mph, EE was 13% higher in the
obese group. While differences in EE may be negligible at slower speeds, the effect of obesity on
relative intensity is more apparent. A speed of 1.55 mph corresponded to 58% and 34% of peak
aerobic capacity in obese and lean individuals, respectively [165]. Differences in EE before and
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after weight loss also highlight the effects of body weight on the energy requirement of walking.
Following extreme weight loss, the metabolic cost of walking is reduced beyond what would be
expected from weight loss alone [166]. Proposed explanations for this inconsistency are
biomechanical alterations and reduced thigh skin friction.
Net EE during walking has also been examined in lean and obese individuals. The net
metabolic cost of walking is calculated by subtracting standing EE from EE during walking.
Using net as opposed to gross values focuses solely on the metabolic cost of walking by
eliminating inequalities in standing EE. After correcting for body mass, the metabolic cost of
standing was 40% lower in obese than lean adults [167]. At 3 mph, gross and net EE were 27%
and 31% higher in obese versus normal weight persons [96]. Net EE may be best-suited to
determine the metabolic cost of the act of walking. However, gross EE is a more relevant
measure when total caloric expenditure is of interest, such as in weight loss programs.

OBJECTIVE PHYSICAL ACTIVITY MONITORS
Many devices are now capable of objectively quantifying PA. Objective monitors have
previously been used to establish thresholds for the classification of PA levels [148]. These
devices have improved accuracy for assessing ambulatory activity and can be used to allow
clinicians to assess adherence to exercise prescriptions.
OBJECTIVE MONITORS VS. SELF-REPORTS
Self-reported measures of PA are subject to recall bias, particularly when used in studies
involving the clinically obese. Obese individuals claiming to be resistant to conventional weight
loss treatment over-reported PA by 51 ± 75% [168]. According to Evans et al. [8] self-reported
PA may poorly reflect actual participation following bariatric surgery, particularly in the first 3
months. They propose that during this time frame, exercise may be incapable of counteracting
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the metabolic changes occurring from such drastic reductions in energy intake. In other words,
the dietary restrictions imposed following weight loss surgery may decrease the metabolic rate to
an extent that cannot be fully compensated through PA. PA levels may be at their lowest in the
weeks immediately following surgery, gradually increasing throughout follow-up. Therefore, PA
at the time of the questionnaire may not represent that of the entire 3-month period.
The correlations between objective devices and subjective questionnaires differ among
studies [169-171]. However, even a high correlation coefficient may simply denote agreement in
the ranking of subjects by PA levels, rather than quantitative agreement [170]. In a pre-surgical
evaluation of PA behaviors in bariatric patients, only 2-5% of the variance in objectively
measured PA was explained by self-reports [10]. Even the International Physical Activity
Questionnaire (IPAQ), having been validated in 12 countries, was only moderately correlated
with accelerometry (r = 0.33) [172]. Furthermore, use of the IPAQ in bariatric patients has been
shown to under-emphasize the relationship between abdominal obesity and PA [173].
With walking being the preferred type of PA for most individuals, accurate assessment of
this behavior is a high priority. However, walking may be especially susceptible to the
discrepancies between self-reports and objective measures. The Behavioral Risk Factor
Surveillance System (BRFSS) fails to assess LTPA and walking separately, resulting in up to 5fold underestimates in self-reported walking distance [170]. It is evident that PA should be
assessed via objective monitoring, at least in combination with self-reports, whenever possible.
In addition to providing more accurate data than self-reports, objective monitors are also capable
of recording PA outside of the clinical setting.
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BENEFITS
Objective PA monitors can also have a positive impact on outcomes of weight loss
programs. It has been proposed that avoiding a change from group-based exercise programs to a
post-intervention PA program relying solely on the individual improves the odds of behavioral
maintenance [132]. Objective monitors allow the individual to record data on daily exercise,
potentially creating a routine of self-monitoring. Poor PA participation following bariatric
surgery has been attributed to a lack of immediate reinforcement [101]. The data displayed on
the objective monitor can provide motivation to exercise after weight loss surgery. Many
monitors are capable of storing several weeks’ worth of data, so medical staff may be able to
reduce the frequency of post-operative appointments used to assess patient adherence to exercise
prescriptions.
PA monitors can effectively increase PA and adherence to PA prescriptions [174-176],
thereby improving health benefits. In comparison to subjects without an objective monitor, those
given a pedometer during a walking intervention had significantly greater improvements in
glucose tolerance [177]. Adults ages 65 and older increased daily step counts by 27% during a
pedometer-driven walking intervention; these gains were lost after removing the devices [178].
Moreover, a recent review found that studies that used a pedometer, daily step goal, and PA log
increased activity by an average of 2,500 steps per day [174].
Some PA monitors are also capable of estimating daily and exercise EE. These devices
become particularly useful when assessing lifestyle changes in bariatric patients. Following
surgery, these individuals experience declines in both resting [179] and walking EE [155].
Accurate estimates of EE would be a valuable resource in maximizing post-surgical weight loss.
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Quantification of PA potentially offers clinicians the opportunity to discern whether patients are
complying with dietary and PA goals.
SPRING-LEVERED PEDOMETERS
Pedometers are devices capable of recording steps taken throughout the day. The simplest
of these devices is the spring-levered pedometer. In order for a pedometer to accurately assess
step counts, the device must be positioned vertically on the body. During walking, steps are
recorded when vertical accelerations of the trunk cause the movement of a spring-suspended
horizontal lever arm. Spring-levered pedometers are less accurate in counting steps of obese
individuals in comparison to normal weight peers. Shepherd et al. [180] found strong positive
correlations between pedometer error and BMI (r = 0.792) and body weight (r = 0.753). The
Yamax SW-200 (Yamax Inc., Tokyo, Japan) undercounted the steps of persons weighing over
100 kg by 11-15% versus 3-7% in those under 100 kg [152]. Excessive adiposity at the waist
may dampen these oscillations, and the force exerted on the lever arm may be insufficient to
record the step [14]. Additionally, a large waist circumference (WC) may tilt the pedometer out
of the vertical plane, decreasing movement of the lever arm required for step counting [13].
When held against the waist of an obese individual with an elastic undergarment, step-counting
accuracy drastically improved [180].
Walking speed is inversely related with pedometer accuracy [13]. When considering selfselected walking speed decreases with increasing BMI [152], this effect is of particular
importance in the evaluation of PA in the severely obese. At speeds of 80 m·min-1 and slower,
WC and BMI were inversely related to pedometer accuracy [14]. While speed and
anthropometrics negatively affected device accuracy at slower speeds, pedometer tilt angle had
the greatest effect across all speeds. Pedometer tilt angle is influenced by adiposity at the waist,
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and thus the accuracy of these devices in persons with class III obesity is decreased. As a result
of differences in self-selected walking speed and tilt angle, the Digi-Walker SW-200 springlevered pedometer may undercount steps in obese persons by twice as much as in normal weight
individuals [11]. However, not all studies have corroborated these findings. At 2.0 and 2.5 mph,
accuracy of the Yamax SW-200 was significantly affected by speed but not BMI [13].
PIEZO-ELECTRIC PEDOMETERS
Similar to spring-levered pedometers, most piezo-electric pedometers are also worn on
the belt or waistband. During ambulation, a piezo-electric accelerometer records the vertical
accelerations of the body, and these data are used to generate estimates of energy expenditure.
Steps are recorded by counting the number of peaks or zero-crossings of the acceleration with
respect to the time recording [14]. These devices are better-suited for obese individuals who
usually walk at slower speeds [152]. Accuracy of the New Lifestyles NL-2000 piezo-electric
pedometer was unaffected by BMI, WC, and pedometer tilt angle [14]. It must be noted that
individuals incapable of walking at 4 mph were excluded from this study, and the average
walking speeds of severely obese individuals fall short of this pace [151, 156, 158]. While BMI
and slow step-rate percentage affected the Digi-Walker accuracy in free-living activity, the
accuracy of the New Lifestyles device was dependent only on stepping rate [11]. The Omron HJ720ITC (Omron Industries) records steps with an absolute error of less than 3% while walking at
both predetermined and self-selected speeds[181]. The Omron is most accurate when worn in the
pocket and recorded with 65% accuracy in obese persons over a 24-hour period [182]. Even
when worn in the pocket, this device was more accurate than the waist-mounted Yamax. This
may be another possible advantage as opposed to spring-levered devices, as a pocket pedometer
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is less reliant on positioning within the vertical plane to record steps. However, the Omron has a
4-second step filter, which leads to undercounting in the free-living environment [183].
STEPWATCH
During walking, more movement occurs at the ankle than at the hip [11]. The StepWatch
is worn at the ankle and uses a dual-axis accelerometer to count steps. This device has been
reported as more accurate than both spring-levered and piezo-electric pedometers at various
speeds, including perfect accuracy in a small sample of severely obese persons [180]. It has since
been used as a criterion pedometer [11, 182]. Where thresholds of 0.30-0.35g are necessary to
record a step in most waist-mounted pedometers, ankle-mounted devices may be more sensitive
[11]. Because it uses accelerometry to record steps, this device is also capable of recording
minute-by-minute stepping rates [180]. This data can be stored for 24-hour periods over multiple
days [11] and is transmitted to a personal computer via an infrared relay [180]. The StepWatch is
also superior to both spring-levered and piezo-electric pedometers during stair climbing [180].
The StepWatch was previously been used in prediction equations to estimate walking EE, and
approximately 66% of the variance in the metabolic cost of walking could be explained from
StepWatch step counts [184].
SENSEWEAR
A newer device combines innovative technology, accelerometry, and proprietary
prediction equations to analyze both total and daily PA. The SenseWearTM Armband
(BodyMedia, Inc. Pittsburgh, PA) is worn on the upper right arm and is capable of counting steps,
estimating EE, and determining intensity of PA over a 24-hour period for multiple days. Data are
collected via a dual-axis accelerometer, galvanic skin response sensor, heat flux sensor, and an
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ambient temperature sensor [185]. PA measurements from this device were similar to those of a
triaxial accelerometer in a study involving persons awaiting bariatric surgery [16].
Even with the advanced technology of this device, energy expenditure assessments
appear far from perfect. When compared to doubly labeled water (DLW), the SenseWear
armband (SWA) significantly underestimated daily EE by 117 kcal in healthy adults (BMI
18≤35) [18]. An intraclass correlation of 0.81 showed that, despite group differences, individual
comparisons between SWA and DLW were similar. Its ability to discriminate between periods of
rest and activity [149] has led to its use in the evaluation of sedentary behaviors in severely
obese individuals [19]. In a study assessing SWA accuracy in obese individuals (BMI 42.3 ± 7.0),
REE was underestimated by an average of 8.8% [186]. Conversely, SWA significantly
overestimated EE during treadmill walking. Detecting changes in grade also appears to pose a
problem when estimating EE. EE was significantly overestimated by 13-27% while walking
without a grade, in contrast to 22% underestimations after adding a 5% grade [185]. These
subjects were far leaner than persons with class III obesity, warranting similar studies in the class
III obese population. Interventions may benefit from using this device to encourage patient selfmonitoring, lowering the cost of care for both subjects and clinicians. Additionally, overweight
and obese individuals reduced blood glucose when receiving group intervention with SWA and
when receiving SWA alone [187], indicating use of this device may be capable of improving
health even in the absence of a structured exercise program.

SUMMARY
Validating objective monitors in severely obese individuals is a crucial step in both
determining volumes of PA necessary for maximizing weight loss and assessing adherence to
exercise prescriptions. Determining which devices are most accurate when worn by these
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individuals will improve quantitative measures of PA in future studies involving the severely
obese. Additionally, estimating the metabolic cost of walking in this population will allow
clinicians to approximate caloric expenditure during walking-based interventions. These results
could lead to the establishment of pre- and post-operative PA recommendations for obese
patients, including those who will undergo bariatric surgery.
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CHAPTER 3
MANUSCRIPT
INTRODUCTION
The prevalence of obesity continues to increase globally [1]. The highest rate of increase
has been in class III, also known as morbid or severe, obesity [32-34]. Over the past twenty years,
the worldwide prevalence of class III obesity has doubled [32]. Behavioral interventions are
capable of reducing body weight in the severely obese [52], and those combining diet and
exercise produce greater long-term results [111]. Bariatric surgery is now considered the most
effective weight loss treatment for severely obese individuals [6], and participation in physical
activity (PA) improves post-surgical weight loss outcomes [188]. Clearly, PA plays an integral
role in both behavioral and surgical weight loss interventions.
Objective monitors record PA data in the free-living environment and have been shown
to increase PA and adherence to PA prescriptions [174-176]. Objective monitoring is particularly
valuable in individuals with class III obesity, as they tend to over-report PA participation [168].
Currently, only self-reported measures have been validated for assessing PA in the bariatric
population [123]. However, only 2-5% of the variance in objectively measured pre-operative PA
is explained by self-reports [10]. Walking comprises 44% of total PA prior to surgery coming
from walking [10], and 76% of National Weight Control Registry participants report walking as
a part of their strategy to maintain weight loss [68]. Thus, accurate assessment of this activity is
necessary.
Pedometers and accelerometers are both capable of recording data during ambulatory
activities. The simplest of these devices is the spring-levered pedometer. Worn at the waist,
pedometers record steps when vertical accelerations of the trunk trigger the movement of a
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spring-suspended horizontal lever arm. However, the accuracy of spring-levered pedometers is
reduced in obese individuals and with slow walking speeds [13, 152, 180]. Piezo-electric
pedometers record vertical accelerations of the body during ambulation, and steps are recorded
by counting the number of peaks or zero-crossings of the acceleration vs. time recording [14].
The accuracy of piezo-electric pedometers is not influenced by BMI [14], but is reduced at
slower walking speeds [11].
Another step-counting device, the StepWatch 3 (Orthocare Innovations, Oklahoma City,
OK) is worn at the ankle and uses a dual-axis accelerometer to count steps. This device is more
accurate than spring-levered and piezo-electric pedometers and had near-perfect accuracy in a
small sample of severely obese persons [180]. It has since been used as a criterion pedometer [11,
182].
Newer devices rely on advanced technology to more accurately quantify the intensity of
free-living PA. The SenseWear Armband (BodyMedia, Inc. Pittsburgh, PA) is worn on the upper
right arm and collects data via a dual-axis accelerometer and galvanic skin response, heat flux,
and ambient temperature sensors [185]. Measured PA intensities from this device were similar to
those from a waist-worn triaxial accelerometer in a study involving persons awaiting bariatric
surgery [16]. The Fitbit (Fitbit Inc., San Francisco, CA) is a wearable PA monitor that records
three-dimensional accelerations using an accelerometer. Both use proprietary algorithms
involving pattern recognition to convert acceleration to energy expenditure (EE), but, to our
knowledge, no study has been published on the accuracy of this device in individuals with severe
obesity. Therefore, the aim of the current study was to determine the accuracy of objective
physical activity monitors during walking in persons with class III obesity.
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METHODS
Study Participants
Participants were 15 individuals between the ages of 19 and 61, who were patients in the
Tennessee Weight Loss & Surgery Center (University of Tennessee Medical Center, Knoxville).
No post-operative patients were included in this study.
Recruitment & Testing
Participants were recruited following medical staff presentations on weight loss surgery
and during support group meetings that prospective surgery patients were required to visit.
Recruitment flyers were also left with medical staff of the Weight Loss and Surgery Center. A
short presentation was given describing the objectives of the study. Afterwards, individuals were
given the opportunity to ask additional questions. All participants signed an informed consent
form.
To be eligible for the study, participants had to be ≥18 years of age, diagnosed with class
III obesity (BMI ≥40 kg·m-2 or BMI ≥35 kg·m-2 with medical comorbidities), and able to walk
for six consecutive minutes without the use of an assistive device. Consent was received from the
attending surgeon prior to beginning any testing. Individuals were deemed ineligible if they did
not meet these criteria or if the physician knew of any other reasons contraindicating
participation in the current study. The University of Tennessee Institutional Review Board and
the University of Tennessee Graduate School of Medicine approved the protocol.
Testing was completed at the University of Tennessee Medical Center. To reduce subject
burden, testing was scheduled during regularly scheduled hospital visits whenever possible.
Inside the Weight Loss & Surgery Center, age, sex, height, weight, hip circumference (HC), and
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waist circumference (WC) were recorded. Walking bouts were completed in a hallway outside
the Weight Loss & Surgery Center.
Objective Physical Activity Monitors
Participants wore shorts/pants with pockets and appropriate footwear for walking-based
activities. Objective monitors were placed on various body locations in accordance with their
respective manufacturers’ instructions. The Fitbit was worn on the right side of the waist. The
SenseWear Pro 2 armband (SWA) (Software Version 7.0) was worn on the right tricep at the
midpoint between the acromion and olecranon processes. The Omron HJ-720ITC pedometer
(Omron Corporation, Kyoto, Japan) was worn in the pants pocket, while the Yamax SW-200
Digiwalker (DW) (Yamasa Corporation, Tokyo, Japan) was clipped to the left side of the
waistband. The StepWatch 3 (SW3) (software version 6.0) was worn on the right ankle, just
above the lateral malleolus.
As a criterion measure, steps were recorded via a hand tally counter by the principal
investigator. Simultaneously, EE was measured by indirect calorimetry using the Oxycon Mobile
portable metabolic system (Carefusion, San Diego, CA). This device was worn on a harness,
with the facemask covering the nose and mouth. The Oxycon O2 and CO2 analyzers were
calibrated using a reference gas tank (16.0% O2 and 4.0% CO2) and room air, and the ventilation
flow meter was calibrated with a 3-L syringe.
Walking Bouts
Participants were instructed to walk in a flat hallway at a self-selected pace for six
consecutive minutes. Investigators instructed participants to select a pace that would allow them
to walk without stopping prior to the sixth minute.
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Statistical Analysis
All statistical analyses were performed using SPSS version 19 for Windows (SPSS, Inc.,
Chicago, IL). Descriptive measures of interest were height, weight, BMI, WC, HC, waist-to-hip
ratio, walking speed, and walking EE. Percent errors for step counts and energy expenditure
estimates were used to evaluate monitor accuracy. For comparison purposes, a value of 0% error
was assigned to the criterion measures. Repeated measures analysis of variance (ANOVA) was
used to determine if monitors differed in percent error for step counts. Pairwise comparisons
were used to determine between-monitor differences in step-counting percent error. A paired
samples t-test was used to determine if monitors differed in estimating Calories. To determine
the metabolic cost of walking during steady state oxygen consumption, the final 3 minutes of
indirect calorimetry values during each walking bout were averaged. To calculate percent errors,
the following equation was used:
% Error = [(Criterion value – Monitor value) / (Criterion value)] * 100%
One sample t-tests were used to examine accuracy. Pearson’s correlations were used to explore
the relationship between height, weight, BMI, walking speed, WC, HC, and WHR and device
accuracy for step counts and Caloric expenditure. All p values were 2-tailed and were deemed
statistically significant if p≤0.05.

RESULTS
Physical characteristics of the participants are depicted in Table 1. All but one individual
had a BMI ≥ 40 kg·m-2, and 14 of the 15 participants were female. Indirect calorimetry
measurements were not obtained on one individual who was tested after a 12-hour fast in an
effort to ensure any potential discrepancies in metabolic measures did not influence our findings.
Step Counting
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Figure 2 shows the results for step-counting percent errors. Repeated measures ANOVA
found PE differed between devices [F(4,11)=4.447, p=0.022)]. Post-hoc comparisons showed
that step-counting percent errors did not differ among the SW3, Omron, or Fitbit. The DW
significantly differed from SW3 (p=0.035), Omron (p=0.008) and Fitbit (p=0.036) but not SWA
(p=0.241). Step-counting percent error of the SWA was significantly greater than Omron
(p=0.020) and marginally greater than Fitbit (p=0.068) and SW3 (p=0.078). One sample t-tests
showed that the DW significantly under-counted steps by approximately 28% [t(14)=2.310,
p=0.037)]. The SWA appeared to under-count steps by 12% [t(14)=1.844, p=0.086].
Energy Expenditure
The SWA and Fitbit provided data on EE. A paired samples t-test found a significant
difference between monitors [t(13)=-4.053, p=0.001)]. A one sample t-test found that during a 6minute walk SWA significantly overestimated Caloric expenditure by 71.6 ± 46.7% (p=0.003),
while the Fitbit slightly overestimated EE by 10.02 ± 22.1% (p=0.114).
Table 1. Participant Characteristics
Physical characteristic
Age (years)
Weight (kg)
BMI (kg·m-2)
WC (cm)
HC (cm)
WHR
Walking EE (ml·kg-1·min-1)
Walking Distance (m)
Walking Speed (km·h-1)

Mean (Standard Deviation)
40.1 (12.5)
131.9 (22.2)
47.0 (5.9)
134.2 (23.2)
145.1 (15.3)
0.92 (0.09)
9.24 (2.15)
388.5 (105)
3.89 (1.05)

N=14 for walking EE.
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Range
19-61
90.5-169.6
37-58.7
99.1-182.9
106.7-172.7
0.78-1.10
5.33-12.93
143.6-535.5
1.43-5.36

Figure 1. Percent errors in step counting during self
self-paced
paced walking in adults with class II
obesity.. To evaluate device accuracy in relation to the hand tally criterion, mean percent
errors were compared. All negative values reflect over
over-counting,
counting, and all positive values
reflect undercounting.

Table 2.. Actual steps recorded by hand tally counter and devices. Data are displayed as
mean steps (standard deviation).
Hand Tally
616.3 (75.0)

SW3
620.1 (79.3)

Omron
645.8 (81.2)

DW
432.2 (273.1)
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SWA
537.5 (138.2)

Fitbit
621.7 (89.8)

Figure 2.. Percent errors in total EE of self-paced
paced walking in adults with class III obesity.
To evaluate device accuracy in relation to the indirect calorimetry criterion, mean percent
errors were compared. All negative values reflect overestimates, and all positive values
reflect underestimates.

Table 3.. Actual Calories recorded by indirect calorimetry, SWA, and Fitbit. Data are
displayed as mean Calories (standard deviation).
Oxycon Mobile
38.0 (8.94)

SWA
62.87 (22.98)
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Fitbit
41.6 (12.47)

DISCUSSION
The prevalence of class III obesity has increased over the past 20 years. Thus, accurate
assessment of this group’s PA behaviors is of utmost importance. In a study involving 86 gastric
bypass patients, leisure-time walking was the most commonly reported form of PA both before
and after surgery [189]. The effectiveness of step-based programs relies heavily on the accuracy
of the step-counting device.
Of the five monitors tested in the current study, only DW step-count percent error
differed significantly from zero. The SW3 produced the smallest margin of error, and no
significant differences were observed among the SW3, Omron, and Fitbit. The SWA
significantly overestimated the metabolic cost of walking, suggesting that the Fitbit may be a
better tool for estimating walking EE in the bariatric population. In the present study, we
observed that the spring-levered, waist-mounted DW undercounted steps by 28%. Past reports
have also shown that the DW significantly undercounts steps in individuals with an elevated
BMI [11, 14].
The placement of the SW3 on the ankle is likely responsible for its high degree of
accuracy. In comparison to waist-mounted devices, ankle-mounted devices are less prone to error
resulting from abdominal adiposity [190]. Slower walking speeds may not produce vertical
accelerations at the hip capable of recording a step; the SW3 overcomes this obstacle by virtue of
its placement on the ankle and also by responding to horizontal accelerations [15].
During the 6-minute bout, the SWA greatly overestimated the metabolic cost of walking.
When obese individuals completed a 5-minute treadmill walk, SWA estimates of EE were
significantly greater than measured values from indirect calorimetry [186]. The reason the SWA
overestimates EE cannot be determined, but the SWA also overestimates the metabolic cost of
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walking in normal weight individuals, although to a lesser extent [185]. It should be noted,
however, that the SWA is capable of accurately assessing 24-hour energy expenditure in healthy
adults when compared with doubly labeled water [191]. The Fitbit only slightly overestimated
EE during the walking bouts, and appears to be a better evaluative instrument for estimating
Caloric expenditure during walking in patients who are severely obese. Interventionists should
consider monitor accuracy when setting PA goals based on Caloric expenditure.
Previous studies have used predetermined walking speeds to assess step-counting
accuracy [11, 13, 14]. We chose to attempt to evaluate the monitors at each participant’s selfselected walking speed, because obese individuals are likely to walk slower than their normal
weight peers [192]. Our participants walked an average of 388.5 m in 6 minutes, or 3.89 km·h-1.
The average metabolic cost of walking of these individuals was 9.24 ± 2.15 ml·kg-1·min-1. These
values are fairly similar to those of 57 obese women (BMI 37.1 ± 3.4 kg·m-2) reported by
Mattson et al. [162]. In that study, the metabolic cost of walking was 11.1 ± 1.4 ml·kg-1·min-1 at
an average self-selected speed of 4.25 km·h-1. In comparison, normal weight women prefer
walking speeds of about 5.3 km·h-1 [193].
The 6-minute walk test (6MWT) is a clinical test commonly used to evaluate functional
capacities of persons with low exercise capacity [194]. The 6MWT requires the participant to
walk as far as possible during the 6-minute period, and walking speed may decrease during the
latter minutes of the test [195]. Average 6MWT distances for persons awaiting bariatric surgery
have ranged from 393 m to 475.7 m [156, 158, 196]. In contrast, our participants were asked to
walk at a self-selected pace that could be maintained for the entirety of the bout. Similar to the
current study’s methods, de Souza et al. [197] instructed individuals awaiting bariatric surgery to
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complete the 6MWT at their regular pace. In that study, the average pre-operative distance
covered was 381.9 m (3.82 km·h-1).
In addition to providing researchers with more accurate data, these devices can also be
used by patients to self-monitor their PA levels during interventions. In a recent review, Bravata
et al. [174] found the use of a pedometer, daily step goal, and PA log led to accumulation of an
additional 2,500 steps·d-1. Severely obese individuals given social support, a pedometer, and a
walking diary increased daily steps by 47% over 18 weeks [198]. Though consistent selfmonitoring of exercise participation has been associated with greater weight loss [199], Burke et
al. [200] note the need for validating and strengthening self-monitoring techniques. Furthermore,
a number of patients remain severely obese following bariatric surgery [90-92], meaning that
both pre- and post-operative PA must be assessed using devices validated for use in the severely
obese. Use of objective monitors has the potential to limit subject burden that often accompanies
PA diaries. While time constraints may prevent an individual from immediately logging
activities, many monitors are capable of recording real-time data and storing it for several weeks.
This feature could potentially allow medical staff to reduce the frequency of post-operative
appointments used to assess patient adherence to exercise prescriptions. Some monitors also
display step counts and Calories, eliminating the need for uploading data in order to receive
feedback.

CONCLUSION
Results of the current study suggest that the SW3, Omron, and Fitbit are all capable of
accurately measuring step counts in individuals with class III obesity, but the DW is not. A new
finding was that the Fitbit was far more accurate than the SWA for estimating Caloric
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expenditure. In conclusion, researchers aiming to assess PA in persons with class III obesity
should consider device accuracy and subject burden.
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